Aim: To investigate the effect of aluminum (Al) on high voltage-dependent calcium current (I HVA ) and its modulation by ginkgolide B (Gin B). Methods: The whole-cell, patch-clamp technique was used to record I HVA from acutely isolated hippocampal CA1 pyramydal neurons in rats. The results indicate that the mechanism of Al affecting I HVA differs at different concentrations, and this may be attributed to its complex actions. Gin B could prevent neurons from injury by inhibiting calcium influx.
Introduction
The accumulation of aluminum (Al) within the body can result in many mental diseases. For example, Al is concentrated in the neurofibrillary tangles and senile plaques of patients with Alzheimer disease (AD) [1] . Al can be attributed to several neurological disorders, such as dialysis syndrome and Guamanian amylotrophic lateral sclerosis-Parkinson's dementia [2] . A number of studies have implicated that Al has no effect on long-term potentiation (LTP) [3] . However, more and more studies have shown that Al can impair LTP [4] and evoke potential in the hippocampus [5] . Studies have also shown that Al affects amino acid neurotransmitters in the hippocampus and enhances glutamate-mediated excitotoxicity, which may be one of the causes of its toxicity [6] . Reports about its mechanism involving ion channels are few and controversial [7] [8] [9] . Extracts from leaves of Ginkgo biloba (EGb) and one of its constituents ginkgolide B have been demonstrated to protect cardiomyocytes and cultured neurons from the in-
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Action of aluminum on high voltage-dependent calcium current and its modulation by ginkgolide B jury induced by hypoxia, ischemia, and the neurotoxicity induced by Aβ [10] [11] [12] . However, it is not known whether the mechanism of this protection of neurons involves ion channels, such as voltage-dependent calcium channels (VDCC).
The present study investigated the actions of Al on I HVA and its modulation by Gin B to examine the neurotoxic mechanisms of Al and the neuroprotective mechanisms of Gin B.
Materials and methods
Reagents Pronase E, forskolin, TEA-Cl, H-89, and HEPES were purchased from Sigma Chemical Company (St Louis, MO, USA). H-89 was dissolved in pipette solution and stored at -20°C. After the whole-cell configuration was constructed, H-89 was dialyzed into the cell through the pipette. Ginkgolide B (BN52021, purity 98.2%) was from the Wuhan Institute of Botany, Chinese Academy of Sciences (Wuhan, China). AlCl 3 was from Jinghua Chemical Company (Beijing, China). The remaining chemicals, unless otherwise stated, were all purchased from the Shanghai Chemical Reagent Plant (Shanghai, China).
Cell isolation Animals were provided by the experimental animal center of Tongji Medical College (Grade II, Certificate No 19-050). Hippocampal CA1 neurons were acutely isolated by enzymatic digestion and mechanical dispersion from 7 to 10-d-old Wistar rats as described in a previous study [13] , with a few modifications. After the animals were killed, the hippocampi were removed and coronary slices were cut at a thickness of approximately 500 µm in ice-cold oxygenated incubation solution within 30 s. The slices were incubated in an external solution saturated with pure O 2 at 32 °C for 1 h, treated with Pronase E 6.0-7.0 kU/L for 25 min in the oxygenated external solution at 32 °C. After digestion the slices were washed six times with external solution and incubated in the same solution saturated with pure O 2 at room temperature. CA1 regions were dissected out and transferred into centrifuge tubes. Hippocampal neurons were dispersed by gentle pipetting using fine glass tubes. After 5 min, the cell suspension was transferred into the recording chamber with a glass coverslip filled with external solution. The cells were left for approximately 30 min before beginning the experiments.
Electrophysiology The cells were placed in a recording chamber mounted on the stage of an inverted microscope (Carl Zeiss, Germany) and superfused with extra cellular solution at room temperature (21-22 °C) . Extracellular solution for recording I HVA was composed of (mmol/L): NaCl 150, KCl 5, MgCl 2 1.1, CaCl 2 2.5, HEPES 10, glucose 10, TTX 0.001, and the pH was adjusted to 7.4 with NaOH. Extracellular application of drugs was carried out by perfusing cells with extracellular solution containing the drugs.
Whole-cell patch experiments were carried out using an Axopatch 200A amplifier (Axon Instruments, Foster City, CA, USA) driven by ISO2 software (MFK, Frankfurt, Germany). In the voltage-clamp experiments, the cells were stepped from -80 mV (50 ms) to -40 mV (200 ms), and then depolarized to 0 mV (200 ms) after briefly hyperpolarizing the membrane potential for 10 ms to -45 mV. The I HVA was activated by the second depolarization. The protocol was applied every 5 s. For analysis of the current-voltage (I-V) relationship, voltage steps (200 ms) were used to depolarize from -40 mV to +40 mV in 10 mV increments. Glass pipettes were used with a resistance of about 3-5 MΩ when filled with a pipette solution composed of (mmol/L): CsCl 140, MgCl 2 2, Mg-ATP 4, TEA-Cl 2, HEPES 10, egtazic acid 11, and the pH was adjusted to 7.2 with CsOH.
Data were acquired at a sampling rate of 10 kHz, filtered at 2 kHz, stored on hard disk and analyzed off-line using the ISO2 analysis software package (MFK, Frankfurt, Germany).
Data analysis The amplitude of I HVA was calculated as the difference between the instantaneous current at the beginning of the experiment and the maximum activating current. Currents were normalized to membrane capacitance to calculate current densities (pA·pF -1 ). Cell membrane capacitance (Cm) was determined online using the ISO2 software program. The activation rate constant and inactivation rate constant were obtained using the ISO2 analysis software. Graphical and statistical data analyses were carried out using Sigmaplot 2001 (SPSS, Chicago, IL, USA) and Origin 6.0 (Microcal Software, Inc, Northampton, MA01060, USA). Data were presented as mean±SEM where appropriate. Statistical analysis were carried out using Student's paired and unpaired ttests and values of P<0.05 were considered statistically significant. Figure 1C ).
Results

Action of Al on
At both low and high concentrations, AlCl 3 inhibited or increased the maximum amplitude of I HVA , but had no effect on the activation threshold potential of I HVA in the I-V relationship (Figure 2A, B) . The G-V curve was unaffected by (Figure 2C ). In addition, AlCl3 had no effect on the activation rate constants at concentrations of 0.1 mmol/L (n=8, P>0.05) or 1.0 mmol/L (n=9, P>0.05).
To gain a better understanding of the action of Al on I HVA , we explored its action on the steady-state inactivation curve of I HVA . (n=12, P>0.05) ( Figure 6A ). In the presence of H-89 (10 µmol/L), I HVA was reduced to 13.1±2.5 pA·pF -1 from 20.1±4.2 pA·pF -1 (n=8, P<0.01). After the current was stable, AlCl 3 0.1 mmol/L was bath applied, and I HVA was reduced to 12.5±2.5 pA·pF -1 . There was no difference in the percentage inhibition with and without H-89 application (n=33, P>0.05) ( Figure 6B ).
Discussion
VDCC in hippocampal neurons are divided into high voltage-dependent channels (HVA) and low voltage-dependent channels (LVA) according to the difference in activation threshold. In the present study we demonstrated that the effect of Al on I HVA differed at different concentrations. Al reduced the amplitude of I HVA irreversibly at low concentrations (0.1 mmol/L). This result supports a previous report on dorsal root ganglion (DRG) neurons [7] . However, Al inhibited and enhanced I HVA as Al concentrations increased The toxic effect of Al in humans is chronic and accumulative and leads to degradation and apoptosis of cells [14] . Acute application of Al inhibits LTP on hippocampal slices of rats as well as in vivo by intracerebroventricular injection. Studies have shown that a series of molecular mechanisms involved in synaptic plasticity, including protein phosphorylation, gene expression, and neurotransmitter release, were regulated by VDCC [15] . LTP induced in different areas of the hippocampus has an intimate relationship with VDCC [16] . The inhibition of I HVA by Al at low concentrations could lead to a reduction in calcium influx, resulting in the reduced release of some neurotransmitters, which might explain impaired LTP in this concentration range. Aluminum increased the amplitude of I HVA at high concentrations and, thus, led to increased calcium influx, resulting in a series of pathological changes, which could cause impairment of LTP and neuronal damage.
In our study, the actions of Al on I HVA differed at different concentrations; thus, it is possible that the mechanism of action is different at different Al concentrations. Protein phosphorylation modulates the function of VDCC and the AC-cAMP-PKA system plays a key role [17] . Thus, forskolin and H-89 were used to investigate whether the action of Al on I HVA is involved in this mechanism. H-89 markedly abolished the increase of I HVA by Al 1.0 mmol/L. Co-superfusion with forskolin plus Al at high concentrations caused more Ca 2+ influx. Together these results indicate that an Al-induced increase in I HVA possibly results from activating cAMP-PKA. However, H-89 did not reverse the action of AlCl 3 totally, suggesting that other mechanisms must contribute to its action on I HVA at high concentrations.
Platt [7] reported that the interactions of aluminum with two different binding sites (within and outside) of calcium channels might contribute to the reduction of VDCCs on DRG neurons. Al has been reported to inhibit Mg-dependent enzymes and to interact with phosphorylation sites [18] . In the present study, the co-application of forskolin and Al did not cancel the reduction and the action of 0.1 mmol/L Al was not affected by H-89, indicating that the mechanism by which Al reduces I HVA at low concentrations might not be involved in the cAMP-PKA system. In addition, Gin B effectively canceled the increase of I HVA by Al at high concentrations, but had almost no effect on the reduction of I HVA by Al at low concentrations, further suggesting that the action of Al at low concentrations on I HVA occurs via a different mechanism. The mechanism by which Al reduced I HVA requires further examination. At intermediate concentration ranges, Al both reduced and enhanced I HVA . The mechanism is not known, but may result from a difference in neurons or from the concentration of Al itself, which indicated that this concentration might be the point at which I HVA moves from being inhibited to enhanced and this might be the reason for its complexity and diversity.
EGb is a complex mixture containing 24% flavonoid glycosides, 6% terpene lactones, such as ginkgolide A, B, C, J and bilobalide, a number of organic acids, and various other constituents. Studies have shown that Gin B has many pharmacological effects (ie preventing atherosclerosis, diminishing coagulation of platelets, ameliorating the circulation system) and has a distinctively protective effect on the central nerve and cardiovascular systems. Clinical studies have shown that oral administration of EGb in human patients with dementia is effective [19] . Gin B can protect cardiocmyocytes and cultured neurons from injury by hypoxia and ischemia through many pathways, for example, by acting as an anti-oxidant [20] , acting as the antagonist of plateletactivating factor [21] and by inhibiting NO-stimulated PKC activity [22] . Furthermore, Gin B has been shown to prevent neurons from glutamate excitoxicity through a reduction in [Ca 2+ ] i [23] and to have an effect on the glycine-gated chloride channel [24] . The present study provides the first evidence that Gin B can cancel the increase of I HVA by Al, and that Gin B can protect neurons by inhibiting I HVA , providing a possible mechanism for clinical treatment in a number of nervous system diseases. The detailed mechanism by which Gin B inhibits I HVA remains to be investigated.
